These alterations recapitulate many of the early cerebral vascular changes seen in AD patients, which are not seen in the 5x familial Alzheimer’s disease (FAD) transgenic mouse model, in which the overexpression of APP is targeted to neurons by the Thy1 promoter [12,48,49]. Here, APP is linked to Alzheimer disease.